StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IMA

ImageneBio, Inc.

IMA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$5.64
+0.10 +1.81%

Key statistics

from XBRL data in SEC filings
Market cap
$63.6M
Revenue (TTM)
$800K
Net income (TTM)
-$49.9M
EPS (TTM)
$-6.79
P/E ratio
Dividend yield
Free cash flow
-$48.3M
Cash
$76.0M
Total assets
$137M
Gross margin
52-week range
$3.94 – $16.50

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Other events Jul 23, 2026 8-K Director or officer change Jun 26, 2026 8-K Director or officer change; Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement; Unregistered sale of equity Apr 13, 2026 8-K Director or officer change Mar 17, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release) Mar 10, 2026 8-K Director or officer change Feb 17, 2026 8-K Director or officer change Dec 18, 2025 8-K Regulation FD disclosure Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Director or officer change Nov 5, 2025 8-K Entered a material agreement; Terminated a material agreement Oct 29, 2025 8-K Director or officer change Oct 22, 2025 8-K Director or officer change Oct 10, 2025 8-K/A Completed an acquisition or disposition Aug 12, 2025 8-K Changed accountants Aug 5, 2025 8-K Director or officer change; Other events Aug 1, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.06; Regulation FD disclosure Jul 29, 2025 8-K Regulation FD disclosure Jul 25, 2025 10-Q Quarter ended 2025-06-30 Jul 24, 2025 8-K Other events Jul 24, 2025 8-K Other events Jul 22, 2025 8-K Director or officer change Jul 16, 2025 8-K Director or officer change; Shareholder vote results; Other events Jul 15, 2025 8-K Other events Jul 11, 2025 8-K Regulation FD disclosure; Other events Jul 1, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure Dec 23, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Director or officer change Jul 12, 2024 8-K Shareholder vote results Jun 10, 2024 8-K Exit or disposal costs; Regulation FD disclosure; Other events May 28, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 10-K Fiscal year ended 2023-12-31 Mar 12, 2024